Stockreport

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at t...

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF REQORSA Has Anti-Tumor Mechanisms and Ability to Trigger Cancer Cell Death AUSTIN, Texas April 9, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NAS [Read more]